Clinical Trial Update: Allogeneic ADSCs and Platelet-Poor Plasma Fibrin Hydrogel to Treat the Patients With Burn Wounds (ADSCs-BWs) [Phase 1, Phase 2]

View source ↗

Summary

Ongoing Phase 1/2 clinical trial evaluating allogeneic adipose-derived stem cells combined with platelet-poor plasma fibrin hydrogel for treatment of second- or…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Burns

Drugs mentioned

• Allogeneic adipose-derived stem cells
• Platelet-poor plasma fibrin hydrogel (platelet-poor plasma fibrin hydrogel)

Snippet

Sponsor: A.A. Partners, LLC | Conditions: Second- or Third-degree Burns | Phase 1, Phase 2 | Status: UNKNOWN